Aker BioMarine AS

BATS-CHIXE:AKBMO Stock Report

Market Cap: NOK 4.3b

Aker BioMarine Past Earnings Performance

Past criteria checks 0/6

Aker BioMarine has been growing earnings at an average annual rate of 42.5%, while the Food industry saw earnings growing at 7.4% annually. Revenues have been growing at an average rate of 7.9% per year.

Key information

42.5%

Earnings growth rate

48.5%

EPS growth rate

Food Industry Growth3.9%
Revenue growth rate7.9%
Return on equity-3.1%
Net Margin-3.3%
Next Earnings Update01 Nov 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Aker BioMarine makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:AKBMO Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24338-11890
31 Mar 24336-8890
31 Dec 23335-9910
30 Sep 23268-4730
30 Jun 232420750
31 Mar 2326814830
31 Dec 2227710870
30 Sep 222741900
30 Jun 2226810880
31 Mar 22269-8880
31 Dec 21262-8840
30 Sep 212623910
30 Jun 21270-8840
31 Mar 21268-14870
31 Dec 20289-5870
30 Sep 20285-26770
30 Jun 20284-28830
31 Mar 20278-18770
31 Dec 19246-24720
31 Dec 18154-1450
31 Dec 17126-18330
30 Sep 17123-15350
30 Jun 17122-11340
31 Mar 17119-5320
31 Dec 16117-2300
30 Sep 16111-8250
30 Jun 161100230
31 Mar 16109-3230
31 Dec 151051230
30 Sep 15105-5230
30 Jun 15103-14240
31 Mar 15111-13240
31 Dec 14112-17260
30 Sep 1499-34110
30 Jun 141094440
31 Mar 141064340
31 Dec 131094700

Quality Earnings: AKBMO is currently unprofitable.

Growing Profit Margin: AKBMO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AKBMO is unprofitable, but has reduced losses over the past 5 years at a rate of 42.5% per year.

Accelerating Growth: Unable to compare AKBMO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AKBMO is unprofitable, making it difficult to compare its past year earnings growth to the Food industry (44.4%).


Return on Equity

High ROE: AKBMO has a negative Return on Equity (-3.09%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/15 02:42
End of Day Share Price 2024/07/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aker BioMarine AS is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Ole-Andreas KrohnDNB Markets
Ola TrovatnDNB Markets